Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27

Cancer

Volumn 117, Issue 7, 2011, Pages 1516-1528

  Hsu, Han Shui ^a,b   Lin, Jiun Han ^a   Huang, Wen Chien ^c   Hsu, Tien Wei ^a   Su, Kelly ^a   Chiou, Shih Hwa ^a,b   Tsai, Yo Ting ^a   Hung, Shih Chieh ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

chemoresistance; Hsp27; lung cancer; stem cell

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CISPLATIN; CYTOTOXIC AGENT; GEMCITABINE; HEAT SHOCK PROTEIN 27; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CANCER STEM CELL; CELL SUBPOPULATION; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; QUERCETIN; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 79952825166     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25599     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96. (Pubitemid 351521864)
2. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukemia after transplantation into Scid mice. Nature. 1994; 367: 645-648. (Pubitemid 24067706)
3. Pardal R, Clarke M, Morrison SJ., Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003; 3: 895-902. (Pubitemid 37500174)
4. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M., The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 1999; 397: 164-168. (Pubitemid 29050921)
5. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444: 756-760. (Pubitemid 44949604)
6. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF., Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004; 14: 43-47. (Pubitemid 38167476)
7. Lanneau D, Brunet M, Frisan E, et al. Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med. 2008; 12: 743-761. (Pubitemid 351718062)
8. Concannon CG, Gorman AM, Samali A., On the role of Hsp27 in regulating apoptosis. Apoptosis. 2003; 8: 61-70. (Pubitemid 36133139)
9. Garrido C, Fromentin A, Bonnotte B, et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res. 1998; 58: 5495-5499. (Pubitemid 28551136)
10. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR., Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer. 1998; 79: 468-475. (Pubitemid 28445267)
11. Berrieman HK, Cawkwell L, O′Kane SL, Smith L, Lind MJ., Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer. Oncol Rep. 2006; 15: 283-286.
12. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63: 5821-5828. (Pubitemid 37187480)
13. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC., Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996; 183: 1797-1806. (Pubitemid 26134320)
14. Bruey JM, Ducasse C, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nature Cell Biol. 2000; 2: 645-651.
15. Pandey P, Farber R, Nakazawa A, et al. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene. 2000; 19: 1975-1981. (Pubitemid 30229410)
16. Xu L, Chen S, Bergan RC., Markapk2 and Hsp27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene. 2006; 25: 2987-2998. (Pubitemid 43780463)
17. Ho MM, Ng AV, Lam S, Hung JY., Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007; 67: 4827-4833. (Pubitemid 46910191)
18. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J., Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999; 54: 960-963.
19. Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung-derived CD133-positive cells. PlosOne. 2008; 3: e2637.
20. Hilbe W, Dirnhofer S, Oberwasserlechner F, et al. CD133 positive endothelial progenitor cells contribute to the tumor vasculature in non-small cell lung cancer. J Clin Pathol. 2004; 57: 965-969. (Pubitemid 39208249)
21. O′Brien CA, Pollett A, Gallinger S, Dick JE., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445: 106-110. (Pubitemid 46067310)
22. Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008; 118: 2111-2120. (Pubitemid 351872330)
23. Meng X, Li M, Wang X, Wang Y, Ma D., Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci. 2009; 100: 1040-1046.
24. Reynolds BA, Weiss S., Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol. 1996; 175: 1-13. (Pubitemid 26150042)
25. Eramo A, Lotti F, Pilozzi E, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008; 15: 504-514. (Pubitemid 351267301)
26. Todaro M, Alea MP, Di Stefano AB, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 2007; 1: 389-402. (Pubitemid 47506537)
27. Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC., PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 2008; 22: 436-448. (Pubitemid 351272752)
28. Seo DC, Sung JM, Cho HJ, et al. Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer. 2007; 6: 75-82.
29. Ciocca DR, Calderwood SK., Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005; 10: 86-103. (Pubitemid 40942470)
30. Oba M, Yano S, Shuto T, Suico MA, Eguma A, Kai H. IFN-Î, down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo. Int J Oncol. 2008; 32: 1317-1324.
31. Dubrovska A, Kim S, Salamone RJ, et al. The role of PTEN/AKT/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A. 2009; 106: 268-273.
32. Bleau AM, Hambardzumyan D, Ozawa T, et al. PTEN/PI3K/AKT pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 2009; 4: 226-235.
33. Hosokawa N, Hirayoshi K, Nakai A, et al. Flavonoids inhibit the expression of heat shock proteins. Cell Struct Funct. 1990; 15: 393-401.
34. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A., Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994; 54: 4952-4957. (Pubitemid 24289427)
35. Jakubowicz-Gil J, Rzymowska J, Gawron A., Quercetin, apoptosis, heat shock. Biochem Pharmacol. 2002; 64: 1591-1595. (Pubitemid 35333420)